Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our MissionEarl W. Davie
Spanning more than four decades, the research of Earl Davie, MD, PhD, has elucidated many areas of the coagulation cascade and led to effective treatments for patients with hemophilia. With colleagues, Dr. Davie devised the revolutionary theory that proteins in the blood plasma are activated by minor proteolysis in order for blood to clot and then proceeded to identify and characterize these proteins in detail throughout the 1960s and 70s. Later, with new DNA technologies, he also isolated, sequenced, and expressed the genes for these clotting factors. For these critical achievements, Dr. Davie received the Society's Henry M. Stratton Medal in 1993. He is professor emeritus of biochemistry at the University of Washington in Seattle